重药控股 (000950.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(重药控股)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 17,668,704,269.0321,094,759,241.6119,620,276,794.0317,298,360,221.1217,855,668,091.9316,796,326,647.9315,878,655,477.15
 营业收入(元) 17,668,704,269.0321,094,759,241.6119,620,276,794.0317,298,360,221.1217,855,668,091.9316,796,326,647.9315,878,655,477.15
二、营业总成本(元) 17,556,004,313.5120,629,917,121.8019,279,821,546.5817,006,462,431.9317,590,001,510.7616,365,759,093.1015,646,178,783.59
 营业成本(元) 16,324,672,820.4919,303,429,890.2817,995,584,878.7215,657,806,906.1616,442,242,856.9715,317,953,059.0914,590,776,932.08
 研发费用(元) 2,740,242.14-744,768.961,497,098.602,076,845.221,040,614.3742,687.1876,038.11
 营业税金及附加(元) 46,636,770.0557,735,513.6243,732,392.2958,283,863.7442,966,648.0550,922,138.3836,453,358.25
 销售费用(元) 476,583,481.66624,120,013.74546,324,284.93580,526,651.88521,544,087.54463,575,315.97468,191,755.90
 管理费用(元) 362,462,880.08331,676,801.43364,208,893.67406,869,501.74312,221,771.02271,916,513.97288,679,036.73
 财务费用(元) 342,908,119.09313,699,671.69328,473,998.37300,898,663.19269,985,532.81261,349,378.51262,001,662.52
  其中:利息费用(元) 356,409,128.19324,169,099.01343,628,880.39312,022,828.13279,714,953.15267,235,027.64264,416,233.49
  其中:利息收入(元) 20,797,547.1820,217,838.6020,988,531.6321,262,395.5215,834,234.7517,923,548.176,919,778.62
 资产减值损失(元) -103,159.47-1,271,165.00-3,202,584.37-35,791,511.97-1,185,228.32377,010.49-3,343,280.18
 信用减值损失(元) -143,221,610.95-89,952,048.05-140,957,446.36-91,360,457.42258,997,295.79-100,757,955.10-171,378,443.10
三、其他经营收益
 加:公允价值变动收益(元) --802,257.06-13,173,112.50-18,591,774.21-1,250,152.9235,333,066.10
 加:投资收益(元) 49,070,752.0984,052,801.8369,531,348.4666,370,133.8181,874,281.0065,869,947.2479,235,090.70
  其中:对联营企业和合营企业的投资收益(元) 54,846,308.0377,647,199.7267,904,125.2767,799,359.3081,434,024.5164,958,645.2172,002,620.53
 资产处置收益(元) -37,460.252,420,439.3716,132.16-179,833.5117,321.9610,209,789.301,112.05
 其他收益(元) 22,405,780.8511,343,588.719,153,852.5421,862,233.016,173,252.1219,842,953.205,250,470.24
四、营业利润(元) 40,814,257.79471,435,736.67275,798,806.94239,625,240.61592,951,729.51424,859,147.04177,574,709.37
 加:营业外收入(元) 9,511,820.563,814,290.0412,300,011.9821,914,957.4017,603,950.535,008,514.303,021,389.97
 减:营业外支出(元) 11,331,895.107,115,838.33494,054.092,185,085.293,294,876.663,828,840.43760,388.61
五、利润总额(元) 38,994,183.25468,134,188.38287,604,764.83259,355,112.72607,260,803.38426,038,820.91179,835,710.73
 减:所得税费用(元) 44,793,555.3270,817,045.4055,840,719.5993,886,522.68109,756,130.2170,345,467.5635,507,806.01
六、净利润(元) -5,799,372.07397,317,142.98231,764,045.24165,468,590.04497,504,673.17355,693,353.35144,327,904.72
(一)按经营持续性分类
  持续经营净利润(元) -5,799,372.07397,317,142.98231,764,045.24165,468,590.04497,504,673.17355,693,353.35144,327,904.72
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 3,953,211.87347,616,995.93166,044,332.35172,491,702.40378,811,421.27289,083,750.96111,888,762.43
  少数股东损益(元) -9,752,583.9449,700,147.0565,719,712.89-7,023,112.36118,693,251.9066,609,602.3932,439,142.29
 扣除非经常性损益后的净利润(元) -4,730,508.45324,653,634.07149,020,220.06160,070,147.95385,742,099.51269,765,188.6959,818,669.95
七、每股收益
 一、基本每股收益(元) 0.010.190.100.100.220.170.06
 二、稀释每股收益(元) 0.010.190.100.100.220.170.06
八、其他综合收益(元) -27,520.65---8,167,104.10---
 归属于母公司股东的其他综合收益(元) -27,506.03---8,517,063.54---
 归属于少数股东的其他综合收益(元) -14.62--349,959.44---
九、综合收益总额(元) -5,826,892.72397,872,709.07231,764,045.24157,301,485.94497,504,673.17355,372,116.86144,327,904.72
 归属于母公司所有者的综合收益总额(元) 3,925,705.84348,172,267.01166,044,332.35163,974,638.86378,811,421.27288,762,685.05111,888,762.43
 归属于少数股东的综合收益总额(元) -9,752,598.5649,700,442.0665,719,712.89-6,673,152.92118,693,251.9066,609,431.8132,439,142.29
公告日期 2023-10-272023-08-252023-04-272023-04-272022-10-272022-08-262022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院